Cargando…

A computational framework of host-based drug repositioning for broad-spectrum antivirals against RNA viruses

RNA viruses are responsible for many zoonotic diseases that post great challenges for public health. Effective therapeutics against these viral infections remain limited. Here, we deployed a computational framework for host-based drug repositioning to predict potential antiviral drugs from 2,352 app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zexu, Yao, Yingjia, Cheng, Xiaolong, Chen, Qing, Zhao, Wenchang, Ma, Shixin, Li, Zihan, Zhou, Hu, Li, Wei, Fei, Teng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900436/ https://www.ncbi.nlm.nih.gov/pubmed/33665567 http://dx.doi.org/10.1016/j.isci.2021.102148

Ejemplares similares

An in silico drug repositioning workflow for host-based antivirals
por: Li, Zexu, et al.
Publicado: (2021)

A chemical-enhanced system for CRISPR-Based nucleic acid detection
por: Li, Zihan, et al.
Publicado: (2021)

Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
por: Jans, David A., et al.
Publicado: (2020)

Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors
por: Dabbagh, Deemah, et al.
Publicado: (2021)

Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)

Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches
por: Cheng, Xiaolong, et al.
Publicado: (2023)

Modified cyclodextrins as broad-spectrum antivirals
por: Jones, Samuel T., et al.
Publicado: (2020)

Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies
por: Soto-Acosta, Ruben, et al.
Publicado: (2021)

The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
por: Jans, David A., et al.
Publicado: (2021)

A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals
por: Olivet, Julien, et al.
Publicado: (2022)

Broad-spectrum antivirals against viral fusion
por: Vigant, Frederic, et al.
Publicado: (2015)

Arbidol as a broad-spectrum antiviral: An update
por: Blaising, Julie, et al.
Publicado: (2014)

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021)

dsRNA as broad-spectrum antiviral therapeutics
por: Xu, Congfei
Publicado: (2022)

931. Host PFKFB3-dependent glycolytic reprogramming as a broad-spectrum antiviral strategy
por: Yuan, Shuofeng, et al.
Publicado: (2023)

The broad-spectrum antiviral functions of IFIT and IFITM proteins
por: Diamond, Michael S., et al.
Publicado: (2012)

Drug repurposing for new, efficient, broad spectrum antivirals
por: García-Serradilla, Moisés, et al.
Publicado: (2019)

Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses
por: Ekins, Sean, et al.
Publicado: (2020)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

Broad-Spectrum Antivirals Derived from Natural Products
por: Tian, Wen-Jun, et al.
Publicado: (2023)

Near-Infrared Dyes: Towards Broad-Spectrum Antivirals
por: Mariewskaya, Kseniya A., et al.
Publicado: (2022)

Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023)

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
por: Chan, Jasper F.W., et al.
Publicado: (2013)

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals
por: Chitalia, Vipul C., et al.
Publicado: (2020)

Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses
por: Tampere, Marianna, et al.
Publicado: (2020)

Systematic optimization of host-directed therapeutic targets and preclinical validation of repositioned antiviral drugs
por: Xie, Dafei, et al.
Publicado: (2022)

The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses
por: Wu, Kan Xing, et al.
Publicado: (2023)

RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals
por: Lesch, Markus, et al.
Publicado: (2019)

Clofazimine derivatives as potent broad-spectrum antiviral agents with dual-target mechanism
por: Zhang, Xintong, et al.
Publicado: (2022)

Development of Broad-Spectrum Antiviral Agents—Inspiration from Immunomodulatory Natural Products
por: Zhang, Mengxun, et al.
Publicado: (2021)

The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition
por: Goodier, John L., et al.
Publicado: (2015)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019)

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine
por: De Clercq, Erik, et al.
Publicado: (1990)

Nitazoxanide: A first-in-class broad-spectrum antiviral agent
por: Rossignol, Jean-François
Publicado: (2014)

Novel activities of safe-in-human broad-spectrum antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2018)

Discovery and development of safe-in-man broad-spectrum antiviral agents
por: Andersen, Petter I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1le17bm98gn20p1i65273d7i35